neoadjuvant alpelisib plus nab-paclitaxel for triple-negative breast cancer
Published 3 years ago • 77 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
4:26
updates in the neoadjuvant management of triple negative breast cancer
-
8:08
parp inhibitors and carboplatin for neoadjuvant triple negative breast cancer treatment
-
8:51
advantages with nab-paclitaxel in tnbc
-
5:46
value of circulating tumor dna after neoadjuvant chemotherapy for triple negative breast cancer
-
1:16
dr. tolaney on platinum-based therapy in neoadjuvant setting of tnbc
-
1:08
neoadjuvant durvalumab shows benefit in triple-negative breast cancer
-
4:22
immunotherapy in early triple-negative breast cancer: new data and future directions
-
1:13
predictive markers of response to durvalumab w/nab-paclitaxel doxorubicin/cyclophosphamide in tnbc
-
4:19
checkpoint inhibitors in the neoadjuvant treatment of triple negative breast cancer
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
6:01
neoadjuvant talazoparib for brca 1/2 mutated triple negative breast cancer
-
1:16
dr. lynce on fda approval of atezolizumab/nab-paclitaxel in tnbc
-
12:47
neoadjuvant treatment in triple-negative breast cancer
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
3:37
tnbc: immunotherapy in the neoadjuvant setting
-
2:52
neoadjuvant and adjuvant therapy in triple negative breast cancer
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
0:50
update on keynote 522, the current standard of care for triple negative breast cancer.